Surgery Doctors in Kankakee, IL Accepting Medicare

8 Surgery doctors found. Showing 1 - 8

Dr. Dong Ouk Kim, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 400 N Wall St, Suite 410, Kankakee, IL 60901 Phone: 815-933-2221    Fax: 815-933-7363

Jeremy Joseph Sugrue, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 555 W Court St Ste 214, Kankakee, IL 60901 Phone: 815-928-6131

Robert Brockman, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 375 N Wall St, Suite P640, Kankakee, IL 60901 Phone: 815-932-0911

Dr. Kay Chow Timbers, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 N Wall St Ste B410, Kankakee, IL 60901 Phone: 815-933-2221    Fax: 815-933-3975

Dr. Soren David Lang, M. D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 N. Wall St, Suite 410, Kankakee, IL 60901 Phone: 815-933-2221    Fax: 815-933-7363

Dr. Jeffrey Lincoln Brown, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 375 N Wall St Ste P420, Kankakee, IL 60901 Phone: 815-932-0911    Fax: 815-932-0631

Gretchen Kathleen Williams, D.O Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 N Wall St Ste B410, Kankakee, IL 60901 Phone: 815-933-2221    Fax: 815-933-3975

Dr. Paul E Rowland, MD Surgery Medicare: Medicare Enrolled Practice Location: 375 N Wall St Ste P420, Kankakee, IL 60901 Phone: 815-932-0911    Fax: 815-932-0631

News Archive

Genomics testing in action: an interview with Kevin Haar, CEO, Appistry

The more connections are made between genes, disease and drugs, and the more that we continue to understand about those connections, the more critical genetic testing will become in modern medicine.

Depression and rheumatoid arthritis

Patients with rheumatoid arthritis (RA), the most common chronic inflammatory arthritis, are twice as likely as other individuals to experience depression.

ImmunoCellular Therapeutics, UPENN sign research agreement

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.

A20 protein plays protective role in diseases associated with chronic bowel inflammation: Scientists

Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.

Juvenile immune arthritis – new treatments wanted

Juvenile immune arthritis (JIA) is a severely undertreated condition, and new medications are badly needed to relieve the signs and symptoms of the illness, according to a new study presented at the 2019 ACR/ARP Annual Meeting.

Read more Medical News

› Verified 6 days ago